Target intelligence / Profile preview

Tissue healing pathway

Molecular classification
Other
01

Overview

The "tissue healing pathway" collectively refers to the orchestrated processes required to repair and regenerate tissue after injury or damage. This involves phases such as hemostasis (cessation of bleeding), inflammation (immune cell infiltration and pathogen clearance), proliferation (cellular migration, proliferation, and extracellular matrix deposition), and remodeling (restoration of tissue architecture and function). Multiple cell types, including macrophages, fibroblasts, keratinocytes, and endothelial cells, as well as cytokines, growth factors, and signaling cascades such as the hedgehog, calcium, and reactive oxygen species pathways, drive these processes. Imbalances in these pathways can result in delayed healing, chronic wounds, or pathological scarring[1][2][3][4][5][6][7][8]. The phrase “tissue healing pathway” is too broad and nonspecific to serve as a molecular therapeutic target; instead, it encompasses numerous individual molecular targets (such as growth factor receptors, matrix metalloproteinases, and inflammatory cytokines), each of which may be a subject of drug development. Therefore, further specification is required to map this functional concept to a distinct and actionable molecular entity.

Other names
Wound healing pathwaytissue repair pathwaywound repair
02

Mechanism of action

Promote cell migration and proliferation, modulate immune response, enhance angiogenesis, regulate extracellular matrix synthesis and remodeling, reduce inflammation

03

Biological functions

InflammationHemostasisCell proliferationTissue remodelingSignal transductionAngiogenesisApoptosis
04

Disease associations

Impaired wound healing (e.g., in diabetes)Fibrosis and excessive scarringChronic woundsInfection susceptibilityInflammation
05

Safety considerations

Excessive or insufficient tissue repair (e.g., hypertrophic scars, chronic non-healing wounds)immune suppression or overactivationoff-target fibrogenesisimpaired angiogenesisinfection risk
06

Interacting drugs

Growth factors (e.g., platelet-derived growth factor, fibroblast growth factor, epidermal growth factor, transforming growth factor-beta)

4 more in the full profile.

07

Biomarkers

Growth factors (PDGF, FGF, EGF, TGF-β)cytokines (IL-6, IL-10)matrix metalloproteinasescollagen levels

Beyond the preview

Go deeper on Tissue healing pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tissue healing pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call